Austrian Post 5.99 DPD courier 6.49 GLS courier 4.49

Language EnglishEnglish
Book Hardback
Book Tamoxifen Philipp Y. Maximov
Libristo code: 01439003
Publishers Springer Basel, July 2013
Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the firs... Full description
? points 573 b
242.55 včetně DPH
Low in stock at our supplier Shipping in 13-16 days
Austria Delivery to Austria

30-day return policy


You might also be interested in


TOP
Le Cordon Bleu Pastry School Le Cordon Bleu / Hardback
common.buy 42.49
TOP
The Tilda Characters Collection Tone Finnanger / Hardback
common.buy 20.86
Hashimoto's Protocol Izabella Wentz / Hardback
common.buy 26.86
Pierre Herme: Chocolate Pierre Herme / Hardback
common.buy 24.40
Brain On Fire: My Month of Madness Susannah Cahalan / Paperback
common.buy 13.58
Attack on Titan 32 Hajime Isayama / Paperback
common.buy 10.05
Mask of Sanity Hervey Cleckley / Paperback
common.buy 32.96
Testosterone Hermann M. Behre / Paperback
common.buy 134.22
Tamoxifen and Breast Cancer Michael W. DeGregorio / Paperback
common.buy 29.85
Tamoxifen Philipp Y. Maximov / Paperback
common.buy 242.55
Tamoxifen John A. Kellen / Hardback
common.buy 206.48
Tamoxifen John A. Kellen / Paperback
common.buy 206.48
Preventive Nutrition ADRIANNE BENDICH / Paperback
common.buy 242.55

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.§This monograph, written by V. Craig Jordan - known as the father of tamoxifen - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a failed morning after contraceptive to become the gold standard for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.

About the book

Full name Tamoxifen
Language English
Binding Book - Hardback
Date of issue 2013
Number of pages 199
EAN 9783034806633
ISBN 3034806639
Libristo code 01439003
Publishers Springer Basel
Weight 478
Dimensions 161 x 241 x 18
Give this book today
It's easy
1 Add to cart and choose Deliver as present at the checkout 2 We'll send you a voucher 3 The book will arrive at the recipient's address

Login

Log in to your account. Don't have a Libristo account? Create one now!

 
mandatory
mandatory

Don’t have an account? Discover the benefits of having a Libristo account!

With a Libristo account, you'll have everything under control.

Create a Libristo account